Results 1 - 5 of 5 for: "Visipaque"
Refine your search:Drug Interactions  

Visipaque
Iodixanol is in a group of drugs called radiopaque (RAY dee oh payk) contrast agents. Iodixanol contains iodine, a substance that absorbs x-rays. Radiopaque contrast agents are used to allow blood vessels, organs, and other non-bony tissues to be seen more clearly on a CT scan or other radiologic...
Consumer Information (Cerner Multum) · More like this · Add to my drug list

Visipaque
VISIPAQUE™ (iodixanol) Injection, 5,5'-[(2-hydroxy-1,3-propanediyl)bis (acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6- triiodo-1,3- benzenedicarboxamide], is a dimeric, isosmolar, nonionic, water-soluble, radiographic contrast medium with a molecular weight of 1550.20 (iodine content...
Professional Monographs (FDA) · More like this

Study shows GE Healthcare's Visipaque Associated with Lower Incidence of Contrast-Induced Nephropathy and Cardiovascular Events in Patients with Chronic Kidney Disease Compared to Iopromide
...renal safety, occurrence of cardiovascular adverse events and diagnostic image quality of GE Healthcare's isosmolar contrast media (CM) iodixanol (Visipaque) and the low-osmolar CM iopromide in select patients concluded iodixanol is associated with lower incidence of contrast-induced neuropathy (CIN)...
Clinical Trial Results (FDA) · More like this

Iodixanol vs Iopromide Study Abstract Presented at American College of Cardiology 2008
...2007 Update of the Guidelines for PCI, recommending the use of isosmolar contrast in patients with CKD who undergo coronary arteriography. ABOUT VISIPAQUE, SELECT SAFETY INFORMATION: In the U.S., Visipaque(TM) (iodixanol) Injection Nonionic Isosmolar VISIPAQUE IS NOT FOR INTRATHECAL USE. All nonionic,...
Clinical Trial Results (FDA) · More like this

Published Study Demonstrates Lower Serum Creatinine Levels after Contrast Media Administration with Iodixanol Than with Iopromide
...said Dr. Richard Vitti, Associate Director Medical & Professional Services in GE Healthcare. ABOUT IODIXANOL, SELECT SAFETY INFORMATION VISIPAQUE had a trend toward fewer patient reports of moderate or severe pain or warmth; however, whether or not this is related to the dose, rate of administration,...
Clinical Trial Results (FDA) · More like this

See also: Urography

Having trouble finding what you want?


MedNotes
Advertisement

(web2)